Global Direct-To-Consumer (DTC) Genetic Testing Market By Test Type (Ancestry & Relationship Testing, Predictive Testing, Nutrigenomic Testing, Carrier Testing, Skincare Testing, Others), By Technology (Single Nucleotide Polymorphism (SNP) chips, Targeted Analysis, Whole Genome Sequencing (WGS), Others), By Sample (Saliva, Urine, Blood, Others), By Distribution Channel (Online and Offline), By Region Competition Forecast & Opportunities, 2027
Global Direct-To-Consumer (DTC) Genetic Testing Market stood at USD 1,254.69 million in 2021 and is expected to grow at a CAGR of 8.97% during the forecast period. The rising prevalence of rare genetic diseases is expected to drive the market expansion. Rising demand for personalized genetic services, as well as increased public awareness around the world, are expected to aid market growth. The Direct-To-Consumer (DTC) genetic testing industry is fragmented, with a few dominant players and other small start-up companies offering superior quality Direct-To-Consumer (DTC) genetic tests at lower costs, which will address affordability issues and positively impact the market growth. The COVID-19 pandemic boosted the direct-to-consumer genetic testing market. During the pandemic, technological advancements have paved the way for new business opportunities in direct-to-consumer genetic testing. The rise in the prevalence of chronic diseases, as well as the introduction of personalized testing kits for niche therapeutic areas, are assisting in the rapid expansion of direct-to-consumer genetic testing. Such service adoption and change has increased demand for such kits. The availability of these kits on online platforms will also have a positive impact on the market statistics
Rising demand for personalized direct-to-consumer genetic testing services will boost the market expansion
The growing popularity of pharmacogenetics will benefit the statistics of the direct-to-consumer genetic testing industry. Pharmacogenetics is a well-known example of gene-based personalization, in which genetic polymorphisms dictate the choice of medicinal treatment that benefits business momentum. Furthermore, consumer comprehension is used to evaluate and regulate personalized tests. The service provider provides descriptive information about the analytical and clinical validity of the tests, which increases the demand in the industry. These personalized tests are also less expensive than traditional genetic tests. Furthermore, personalized direct-to-consumer genetic test results can be obtained quickly using simple and noninvasive methods. These previously mentioned factors will propel the overall market share.
Increasing use of Genetic Information across the Healthcare Industry will augment the market progress
The ancestry & relationship testing segment will account for approximately 32% of the market in 2021, as costs for genetic ancestry tests have decreased in recent years, thereby increasing demand. In addition, interest in ancestry tests has grown dramatically in developed countries, including the United States, which adds to the segmental momentum. Ancestry testing, also called genetic genealogy, allows people to learn about their family history through historical documentation. It provides clues about an individual's ancestors among people of similar backgrounds by examining DNA variations. FamilyTreeDNA, for example, offers Family Finder DNA tests to find DNA matches and family connections. This also aids in determining ancestry history by comparing DNA to DNA from archaeological dig sites. As a result, ancestry and relationship testing are becoming more popular.
North America contributing to the Market Growth
North America's industry acquired around 44% of the market in 2021 and is expected to grow significantly in the coming years. Rising public awareness of direct-to-consumer genetic tests is attributed to high growth in the United States and Canada. Furthermore, increased internet use among residents in densely populated areas of the countries will benefit the market expansion. Similarly, a simplified regulatory process in the region will spur market growth. The US Food and Drug Administration, for example, streamlines regulations and ensures that tests are analytically and clinically valid without the involvement of a healthcare intermediary. All these factors contribute to an increase in demand for direct-to-consumer genetic testing.
Rising public awareness and consumer empowerment will support market growth
A national survey found that awareness of genetic testing in the United States increased from 31% to 38% between 2007 and 2014, and a social media survey found that 47% of users were familiar with the Direct-To-Consumer (DTC)-GT concept. The shift from passive to empowered customers has created opportunities for businesses to respond in a variety of sectors, including genetic testing. Direct-To-Consumer (DTC)-inherent GT's accessibility is a significant benefit, allowing consumers free access to their own genetic information as well as personalized insights and recommendations. A sense of empowerment is a key driver of Direct-To-Consumer (DTC)-GT adoption; 80% of early adopters of Direct-To-Consumer (DTC)-GT services report a sense of empowerment from their results and “curiosity" as a primary motivation. As a result, 90% of Direct-To-Consumer (DTC)-GT firms use the emotional appeal of 'empowerment' in their marketing strategies.
The Global Direct-To-Consumer (DTC) Genetic Testing Market is segmented based on test type, technology, sample, distribution channel, and region. By test type, the market can be categorized into ancestry & relationship testing, predictive testing, nutrigenomic testing, carrier testing, skincare testing, and others. In terms of technology, the market can be classified into single nucleotide polymorphism (SNP) chips, targeted analysis, whole genome sequencing (WGS), and others. Based on sample, the market is divided into saliva, Urine, blood, and others. By distribution channel, the market can be split into online and offline. Regionally, North America dominated the market followed by Europe, Asia Pacific, Middle East & Africa and South America. The United States dominated the Direct-To-Consumer (DTC) Genetic Testing Market among all the countries and stood at USD 395.80 million in 2021 on account of growing prevalence of genetic disorders along with growing awareness related to at home genetic testing in the country.
23andMe, Inc., Ancestry.com, LLC, Color Health, Inc., Helix OpCo LLC, Counsyl., My Heritage., Living DNA, Mapmygenome india Limited, Full Genomes Corporation, Direct Laboratory Services, LLC are among the major market players in the Global Direct-To-Consumer (DTC) Genetic Testing Market.
In this report, Global Direct-To-Consumer (DTC) Genetic Testing Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook